BSI CTMS vs L7|ESP
BSI CTMS
bsi-lifesciences.comL7|ESP
l7informatics.comSide by side
| Figure | BSI CTMS | L7|ESP |
|---|---|---|
| Price from | — | — |
| Free plan | — | — |
| Free trial | — | — |
| Open source | — | — |
| Web | Yes | Yes |
| API | Yes | — |
| Self-hosted | — | Yes |
| Plans published | 1 | 0 |
| Spec score · Research Project Management Software | 7.5 (#9) | 7.3 (#14) |
| Compliance | BSI says CTMS is specified and validated for 21 CFR Part 11, ICH-GCP E6(R2), EMA/INS/GCP/112288/2023, and GDPR requirements. | L7|ESP is described as designed for GxP operations, including GLP, GCP, and GMP, with audit trails and traceability. |
| Headquarters | Baden, Switzerland | Austin, Texas, USA |
Plans
In their own words
BSI CTMS
BSI CTMS is a cloud-delivered clinical trial management system for pharmaceutical, biotechnology, diagnostics, med-tech, contract research, and academic organizations. Its unified platform combines CTMS functions with an electronic trial master file, study startup, and trial supply management. Teams can plan studies, track milestones, follow recruitment and randomization status, monitor sites, manage investigators, and record issues. The eTMF handles document creation, review, approval, electronic signatures, version management, and study-partner access. Risk-based monitoring, monitoring-visit workflows, offline monitoring, and an integrated learning management system support oversight and training records. Users can build reports from CTMS data and export them to Word, Excel, or PowerPoint. Listed interfaces cover Veeva eTMF, EDC, portfolio and project management, clinical data warehouses, and Active Directory single sign-on. BSI says the system is validated for specified clinical-trial and privacy requirements. Pricing is on request.
L7|ESP
L7|ESP brings research, development, manufacturing and quality workflows into one platform for scientific data contextualization. Its Research package combines the platform, L7 LIMS and L7 Notebooks for experiments involving compounds, molecules or tests. L7|MASTER is a low-code tool for defining reusable scientific data and process models, while L7|HUB stores and governs workflows, models and instrument connectors for FAIR data practices. Connector areas include sequencing, PCR, label printing, quantification, automated nucleic acid extraction, imaging and liquid handling, with examples such as Illumina, Oxford Nanopore and PacBio Sequel IIe. Analytics can surface in Snowflake, Tableau and Power BI. L7|SYNAPSE supports protocol assembly, deviation suggestions and anomaly identification, with compliance-threshold actions validated before execution. The platform is designed for GxP operations with audit trails and traceability, and can run on public or private cloud or on-premise. Pricing is on request; L7|EXCHANGE is estimated for 2027.